Works by Jun Goo Kang

Results: 45
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16

    Baseline Renal Function Predicts Hyponatremia in Liver Cirrhosis Patients Treated with Terlipressin for Variceal Bleeding.

    Published in:
    Gastroenterology Research & Practice, 2017, p. 1, doi. 10.1155/2017/7610374
    By:
    • Kim, Sung Eun;
    • Jung, Dong Min;
    • Park, Ji Won;
    • Ju, Yeonmi;
    • Lee, Bohyun;
    • Kim, Hyoung Su;
    • Suk, Ki Tae;
    • Jang, Myoung Kuk;
    • Park, Sang Hoon;
    • Kang, Jun Goo;
    • Soh, Jae Seung;
    • Lim, Hyun;
    • Kang, Ho Suk;
    • Moon, Sung Hoon;
    • Kim, ChulSik;
    • Lee, SeongJin;
    • Kim, Jong Hyeok;
    • Lee, Myung Seok;
    • Kim, Dong Joon;
    • Ihm, Sung-Hee
    Publication type:
    Article
    17
    18

    I n vitro and long-term (2-year follow-up) in vivo osteogenic activities of human periosteum-derived osteoblasts seeded into growth factor-releasing polycaprolactone/pluronic F127 beads scaffolds.

    Published in:
    Journal of Biomedical Materials Research, Part A, 2017, v. 105, n. 2, p. 363, doi. 10.1002/jbm.a.35907
    By:
    • Lee, Jin Ho;
    • Woo, Dong Kyun;
    • Kim, Tae Ho;
    • Kang, Jun Goo;
    • Yun, Jeong‐Won;
    • Park, Jin‐Ho;
    • Park, Bong‐Wook;
    • Kang, Young‐Hoon;
    • Rho, Gyu‐Jin;
    • Jang, Si‐Jung;
    • Park, Ji‐Sung;
    • Lee, Hee‐Chun;
    • Yoon, Young Min;
    • Hwang, Tae Sung;
    • Kim, Deok Ryong;
    • Hwang, Sun‐Chul;
    • Lee, Dong Hoon;
    • Kim, Ho Young;
    • Oh, Se Heang;
    • Byun, June‐Ho
    Publication type:
    Article
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34

    Efficacy and safety of a fixed‐dose combination of dapagliflozin and linagliptin (AJU‐A51) in patients with type 2 diabetes mellitus: A multicentre, randomized, double‐blind, parallel‐group, placebo‐controlled phase III study

    Published in:
    Diabetes, Obesity & Metabolism, 2025, v. 27, n. 1, p. 81, doi. 10.1111/dom.15985
    By:
    • Hong, Jun Hwa;
    • Kim, Myung Jin;
    • Min, Kyung Wan;
    • Won, Jong Chul;
    • Kim, Tae Nyun;
    • Lee, Byung‐Wan;
    • Kang, Jun Goo;
    • Kim, Jae Hyeon;
    • Park, Jung Hwan;
    • Ku, Bon Jeong;
    • Lee, Chang Beom;
    • Kim, Sang Yong;
    • Shon, Ho Sang;
    • Lee, Woo Je;
    • Park, Joong‐Yeol
    Publication type:
    Article
    35
    36

    Efficacy and safety of enavogliflozin, a novel SGLT2 inhibitor, in Korean people with type 2 diabetes: A 24‐week, multicentre, randomized, double‐blind, placebo‐controlled, phase III trial.

    Published in:
    Diabetes, Obesity & Metabolism, 2023, v. 25, n. 7, p. 1865, doi. 10.1111/dom.15046
    By:
    • Kwak, Soo Heon;
    • Han, Kyung Ah;
    • Kim, Kyung‐Soo;
    • Yu, Jae Myung;
    • Kim, EunSook;
    • Won, Jong Chul;
    • Kang, Jun Goo;
    • Chung, Choon Hee;
    • Oh, Seungjoon;
    • Choi, Sung Hee;
    • Won, Kyu Chang;
    • Kim, Sin Gon;
    • Cho, Seung Ah;
    • Cho, Bo Young;
    • Park, Kyong Soo
    Publication type:
    Article
    37
    38
    39
    40
    41
    42
    43
    44
    45